CON
Concentra Group Holdings Parent, Inc.
Medical - Equipment & Services
Market Cap$2.92B
5Y Perf.-2.1%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
CON vs UNH
Revenue, margins, valuation, and 5-year total return — side by side.
UNH
UnitedHealth Group Incorporated
Medical - Healthcare Plans
Market Cap$330.28B
5Y Perf.-36.8%
CON vs UNH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | CON | UNH |
|---|---|---|
| Industry | Medical - Equipment & Services | Medical - Healthcare Plans |
| Market Cap | $2.92B | $330.28B |
| Revenue (TTM) | $2.09B | $449.71B |
| Net Income (TTM) | $153M | $12.04B |
| Gross Margin | 28.4% | 18.8% |
| Operating Margin | 15.5% | 4.2% |
| Forward P/E | 15.6x | 19.9x |
| Total Debt | $1.95B | $78.39B |
| Cash & Equiv. | $183M | $24.36B |
CON vs UNH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
CON
UNH
| Stock | Jul 24 | May 26 | Return |
|---|---|---|---|
| Concentra Group Hol… (CON) | 100 | 97.9 | -2.1% |
| UnitedHealth Group … (UNH) | 100 | 63.2 | -36.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CON vs UNH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: CON leads in 5 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. UnitedHealth Group Incorporated is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
CON
Concentra Group Holdings Parent, Inc.
The Defensive Pick
CON carries the broadest edge in this set and is the clearest fit for defensive.
- Beta 0.69, yield 52.8%, current ratio 1.42x
- Lower P/E (15.6x vs 19.9x)
- 7.3% margin vs UNH's 2.7%
Best for: defensive
UNH
UnitedHealth Group Incorporated
The Insurance Pick
UNH is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 25 yrs, beta 0.59, yield 2.4%
- Rev growth 11.8%, EPS growth -14.7%, 3Y rev CAGR 11.4%
- 217.0% 10Y total return vs CON's 3.2%
Best for: income & stability and growth exposure
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | UNH | 11.8% revenue growth vs CON's 3.4% |
| Value | CON | Lower P/E (15.6x vs 19.9x) |
| Quality / Margins | CON | 7.3% margin vs UNH's 2.7% |
| Stability / Safety | UNH | Beta 0.59 vs CON's 0.69, lower leverage |
| Dividends | CON | 52.8% yield, 2-year raise streak, vs UNH's 2.4% |
| Momentum (1Y) | CON | +6.9% vs UNH's -7.9% |
| Efficiency (ROA) | CON | 5.4% ROA vs UNH's 3.9%, ROIC 11.1% vs 9.2% |
CON vs UNH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2025
CON vs UNH — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLCONLAGGINGUNH
UNHUnitedHealth Group In…
0leads
CONConcentra Group Holdi…
4leads
6 Total Categories
CATEGORYLEADERvs UNHMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
CON6/6
Valuation MetricsMultiples, price ratios, and targets
CON4/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
CON6/9
Total Returns1Y, 3Y, 5Y total returns with dividends
CON5/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
CON leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 215.2x CON's $2.1B. Profitability is closely matched — net margins range from 7.3% (CON) to 2.7% (UNH). On growth, CON holds the edge at +17.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | CONConcentra Group H… | UNHUnitedHealth Grou… |
|---|---|---|
| RevenueTrailing 12 months | $2.1B | $449.7B |
| EBITDAEarnings before interest/tax | $395M | $23.2B |
| Net IncomeAfter-tax profit | $153M | $12.0B |
| Free Cash FlowCash after capex | $176M | $19.7B |
| Gross MarginGross profit ÷ Revenue | +28.4% | +18.8% |
| Operating MarginEBIT ÷ Revenue | +15.5% | +4.2% |
| Net MarginNet income ÷ Revenue | +7.3% | +2.7% |
| FCF MarginFCF ÷ Revenue | +8.4% | +4.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +17.0% | +2.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +5.7% | +0.7% |
CON leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
CON leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 17.6x trailing earnings, CON trades at a 36% valuation discount to UNH's 27.5x P/E. On an enterprise value basis, CON's 12.6x EV/EBITDA is more attractive than UNH's 16.5x.
| Metric | CONConcentra Group H… | UNHUnitedHealth Grou… |
|---|---|---|
| Market CapShares × price | $2.9B | $330.3B |
| Enterprise ValueMkt cap + debt − cash | $4.7B | $384.3B |
| Trailing P/EPrice ÷ TTM EPS | 17.55x | 27.50x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.63x | 19.87x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 12.62x | 16.48x |
| Price / SalesMarket cap ÷ Revenue | 1.54x | 0.74x |
| Price / BookPrice ÷ Book value/share | 9.79x | 3.26x |
| Price / FCFMarket cap ÷ FCF | 13.90x | 20.55x |
CON leads this category, winning 4 of 6 comparable metrics.
Profitability & Efficiency
CON leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
CON delivers a 37.4% return on equity — every $100 of shareholder capital generates $37 in annual profit, vs $12 for UNH. UNH carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to CON's 6.53x. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs CON's 5/9, reflecting solid financial health.
| Metric | CONConcentra Group H… | UNHUnitedHealth Grou… |
|---|---|---|
| ROE (TTM)Return on equity | +37.4% | +11.5% |
| ROA (TTM)Return on assets | +5.4% | +3.9% |
| ROICReturn on invested capital | +11.1% | +9.2% |
| ROCEReturn on capital employed | +13.8% | +9.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 |
| Debt / EquityFinancial leverage | 6.53x | 0.77x |
| Net DebtTotal debt minus cash | $1.8B | $54.0B |
| Cash & Equiv.Liquid assets | $183M | $24.4B |
| Total DebtShort + long-term debt | $2.0B | $78.4B |
| Interest CoverageEBIT ÷ Interest expense | 3.09x | 4.71x |
CON leads this category, winning 6 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
CON leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CON five years ago would be worth $10,318 today (with dividends reinvested), compared to $9,722 for UNH. Over the past 12 months, CON leads with a +6.9% total return vs UNH's -7.9%. The 3-year compound annual growth rate (CAGR) favors CON at 1.0% vs UNH's -7.7% — a key indicator of consistent wealth creation.
| Metric | CONConcentra Group H… | UNHUnitedHealth Grou… |
|---|---|---|
| YTD ReturnYear-to-date | +17.9% | +8.8% |
| 1-Year ReturnPast 12 months | +6.9% | -7.9% |
| 3-Year ReturnCumulative with dividends | +3.2% | -21.4% |
| 5-Year ReturnCumulative with dividends | +3.2% | -2.8% |
| 10-Year ReturnCumulative with dividends | +3.2% | +217.0% |
| CAGR (3Y)Annualised 3-year return | +1.0% | -7.7% |
CON leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
Evenly matched — CON and UNH each lead in 1 of 2 comparable metrics.
Risk & Volatility
UNH is the less volatile stock with a 0.59 beta — it tends to amplify market swings less than CON's 0.69 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CON currently trades 92.4% from its 52-week high vs UNH's 88.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | CONConcentra Group H… | UNHUnitedHealth Grou… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.69x | 0.59x |
| 52-Week HighHighest price in past year | $24.68 | $409.70 |
| 52-Week LowLowest price in past year | $18.55 | $234.60 |
| % of 52W HighCurrent price vs 52-week peak | +92.4% | +88.8% |
| RSI (14)Momentum oscillator 0–100 | 54.1 | 83.3 |
| Avg Volume (50D)Average daily shares traded | 638K | 8.1M |
Evenly matched — CON and UNH each lead in 1 of 2 comparable metrics.
Analyst Outlook
Evenly matched — CON and UNH each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates CON as "Buy" and UNH as "Buy". Consensus price targets imply 35.8% upside for CON (target: $31) vs 5.9% for UNH (target: $385). For income investors, CON offers the higher dividend yield at 52.80% vs UNH's 2.39%.
| Metric | CONConcentra Group H… | UNHUnitedHealth Grou… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $31.00 | $385.43 |
| # AnalystsCovering analysts | 4 | 52 |
| Dividend YieldAnnual dividend ÷ price | +52.8% | +2.4% |
| Dividend StreakConsecutive years of raises | 2 | 25 |
| Dividend / ShareAnnual DPS | $12.05 | $8.70 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.5% | +1.7% |
Evenly matched — CON and UNH each lead in 1 of 2 comparable metrics.
Key Takeaway
CON leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 2 categories are tied.
Best OverallConcentra Group Holdings Pa… (CON)Leads 4 of 6 categories
Loading custom metrics...
CON vs UNH: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CON or UNH a better buy right now?
For growth investors, UnitedHealth Group Incorporated (UNH) is the stronger pick with 11.
8% revenue growth year-over-year, versus 3. 4% for Concentra Group Holdings Parent, Inc. (CON). Concentra Group Holdings Parent, Inc. (CON) offers the better valuation at 17. 6x trailing P/E (15. 6x forward), making it the more compelling value choice. Analysts rate Concentra Group Holdings Parent, Inc. (CON) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CON or UNH?
On trailing P/E, Concentra Group Holdings Parent, Inc.
(CON) is the cheapest at 17. 6x versus UnitedHealth Group Incorporated at 27. 5x. On forward P/E, Concentra Group Holdings Parent, Inc. is actually cheaper at 15. 6x.
03Which is the better long-term investment — CON or UNH?
Over the past 5 years, Concentra Group Holdings Parent, Inc.
(CON) delivered a total return of +3. 2%, compared to -2. 8% for UnitedHealth Group Incorporated (UNH). Over 10 years, the gap is even starker: UNH returned +217. 0% versus CON's +3. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CON or UNH?
By beta (market sensitivity over 5 years), UnitedHealth Group Incorporated (UNH) is the lower-risk stock at 0.
59β versus Concentra Group Holdings Parent, Inc. 's 0. 69β — meaning CON is approximately 18% more volatile than UNH relative to the S&P 500. On balance sheet safety, UnitedHealth Group Incorporated (UNH) carries a lower debt/equity ratio of 77% versus 7% for Concentra Group Holdings Parent, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CON or UNH?
By revenue growth (latest reported year), UnitedHealth Group Incorporated (UNH) is pulling ahead at 11.
8% versus 3. 4% for Concentra Group Holdings Parent, Inc. (CON). On earnings-per-share growth, the picture is similar: Concentra Group Holdings Parent, Inc. grew EPS -8. 5% year-over-year, compared to -14. 7% for UnitedHealth Group Incorporated. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CON or UNH?
Concentra Group Holdings Parent, Inc.
(CON) is the more profitable company, earning 8. 8% net margin versus 2. 7% for UnitedHealth Group Incorporated — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CON leads at 16. 0% versus 4. 2% for UNH. At the gross margin level — before operating expenses — CON leads at 27. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CON or UNH more undervalued right now?
On forward earnings alone, Concentra Group Holdings Parent, Inc.
(CON) trades at 15. 6x forward P/E versus 19. 9x for UnitedHealth Group Incorporated — 4. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CON: 35. 8% to $31. 00.
08Which pays a better dividend — CON or UNH?
All stocks in this comparison pay dividends.
Concentra Group Holdings Parent, Inc. (CON) offers the highest yield at 52. 8%, versus 2. 4% for UnitedHealth Group Incorporated (UNH).
09Is CON or UNH better for a retirement portfolio?
For long-horizon retirement investors, UnitedHealth Group Incorporated (UNH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
59), 2. 4% yield, +217. 0% 10Y return). Both have compounded well over 10 years (UNH: +217. 0%, CON: +3. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CON and UNH?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CON is a small-cap deep-value stock; UNH is a large-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(CON: 17.0% · UNH: 2.0%)Net Margin>
%
(CON: 7.3% · UNH: 2.7%)P/E Ratio<
x
(CON: 17.6x · UNH: 27.5x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.